Revance Therapeutics Inc
SWB:RTI
Revance Therapeutics Inc
SWB:RTI
Price:
3.44
EUR
Market Closed
Market Cap:
€997.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
R
|
Revance Therapeutics Inc
SWB:RTI
|
US |
|
AGFA Gevaert NV
OTC:AFGVY
|
BE |
|
O
|
Orezone Gold Corp
SWB:OEX
|
CA |
|
C
|
Commercial Vehicle Group Inc
NASDAQ:CVGI
|
US |
|
T
|
Trinity Biotech PLC
SWB:TRBA
|
IE |
|
M
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
OTC:MURGY
|
DE |
|
N
|
New York Times Co
DUS:NYT
|
US |
|
M
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
DUS:MUV2
|
DE |
|
New World Development Co Ltd
HKEX:17
|
HK |
|
A
|
AGFA Gevaert NV
SWB:AGE
|
BE |
|
C
|
Centrais Eletricas Brasileiras SA
F:L3XB
|
BR |
|
R
|
Rubico Inc
NASDAQ:RUBI
|
GR |
Multiples-Based Value
The Multiples-Based Value for 
Revance Therapeutics Inc (RTI) under the Base Case is hidden
EUR.
Compared with the current market price of 3.44 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RTI Multiples-Based Value
LOCKED
